# Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

> **NCT03827447** · PHASE1 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 7 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Vancomycin Oral Capsule
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT03827447
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-17
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03827447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03827447, "Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03827447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*